510(k) Report

510(k) · Cleared

Cleared

PhySoftAMS®

K232283510(k) TraditionalCleared Dec 14, 2023136-day reviewClass II21 CFR 876.5820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Physician Software Systems, LLC · MQS System, Hemodialysis, Access Recirculation Monitoring

Cleared on Dec 14, 2023 as substantially equivalent to K130579 (Physicians Software Systems, LLC, 2013) after a 136-day review. Its family tree reaches back 6 generations to 1997.

Decided
Dec 14, 2023
Review
136 days
Class
Class II
Product code
MQS
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K960817 (1997). 7 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK960817 HD01-Series Transonic Hemodialysis Monitor (R%,QA,CO,QB,QB2)Transonic Systems, Inc. · 1997 · Recalled
  2. 5 generations backK980906 Transonic Hemodialysis Monitor, Cardiac Output, Model HD01-COTransonic Systems, Inc. · 1998
  3. 4 generations backK030456 Vasc-AlertVasc-Alert, LLC · 2003
  4. 3 generations backK042566 Vasc-AlertVasc-Alert, Inc. · 2004
  5. 2 generations backK093834 Crit-Line Anemia Management SoftwareHema Metrics, LLC · 2010
  6. 1 generation backK130579 Physoft AmsPhysicians Software Systems, LLC · 2013
  7. This deviceK232283 PhySoftAMS®Physician Software Systems, LLC · 2023
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K960817HD01-Series Transonic Hemodialysis Monitor (R%,QA,CO,QB,QB2)Transonic Systems, Inc.19971
−5K980906Transonic Hemodialysis Monitor, Cardiac Output, Model HD01-COTransonic Systems, Inc.1998—
−4K030456Vasc-AlertVasc-Alert, LLC2003—
−3K042566Vasc-AlertVasc-Alert, Inc.2004—
−2K093834Crit-Line Anemia Management SoftwareHema Metrics, LLC2010—
−1K130579Physoft AmsPhysicians Software Systems, LLC2013—
0 (this device)K232283PhySoftAMS®Physician Software Systems, LLC2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200010
FIG. 1 — Lineage of K232283, 1997–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K130579Physoft Ams
Summary page 5
…n Name: Anemia Management System Trade Name: PhySoft AMS™ 510(k): K130579 Classification Name: Hemodialysis System and Accessories Classification Panel: 7…
Physicians Software Systems, LLC2013—
†K180410Dosis SAMDosis, Inc.2019—

Also cleared against K130579: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 6 companies; a new generation was cleared every 4.8 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • 1 other device also cites its predicate K130579.

How does its category compare?

All MQS devices

MQS System, Hemodialysis, Access Recirculation Monitoring: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · MQS

1in 2023

2013: 12019: 12023: 1
2007high 1 (2013) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQS

Too few MQS 510(k)s in any year since 2007 to give a median.

Recalls per year · MQS

No recall names MQS since 2007.

Adverse event reports per year · MQS

5in 2013

2007: 682008: 62009: 212010: 102011: 12012: 52013: 5
2007high 68 (2007) · low 0 (2014)2025

MAUDE reports naming product code MQS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—068
20080—06
20090—021
20100—010
20110—01
20120—05
20131—05
20140—00
20150—00
20160—00
20170—00
20180—00
20191—00
20200—00
20210—00
20220—00
20231—00
20240—00
20250—00
20260—0—

What is it indicated for?

The PhySoft Anemia Management System® (PhySoftAMS®) is a software application used to obtain, track and trend patient data pertaining to the management of anemia, and to provide a schedule of erythropoiesis-stimulating agent (ESA) dosage recommendations to help achieve and maintain target hemoglobin levels in dialysis patients. PhySoftAMS® is intended to help physicians, nurses, clinicians, and anemia managers manage anemia in adult stage 5 chronic…

Read the full statement (157 words)

The PhySoft Anemia Management System® (PhySoftAMS®) is a software application used to obtain, track and trend patient data pertaining to the management of anemia, and to provide a schedule of erythropoiesis-stimulating agent (ESA) dosage recommendations to help achieve and maintain target hemoglobin levels in dialysis patients. PhySoftAMS® is intended to help physicians, nurses, clinicians, and anemia managers manage anemia in adult stage 5 chronic kidney disease (CKD) patients.

PhySoftAMS® is not a substitute for, but is rather intended to assist, clinical judgment. The erythropoiesis-stimulating agent (ESA) dosing regimen options calculated by this device are intended to be used by qualified and trained medical personnel to inform the optimization of the dosage of ESAs in accordance with their approved labeling in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgment. No medical decision should be based solely on the patient Hgb response to dosing regimen options calculated by this device.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K232283: PhySoftAMS®.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K232283

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026